Lofexidine vs Clonidine in Opioid Detox: What to Ask

If you or someone you love is preparing for opioid detox, you will probably hear two medication names early on: lofexidine and clonidine. Both are used to take the edge off withdrawal. Neither one is a treatment for opioid use disorder on its own, and knowing the difference before admission makes the intake conversation shorter and the plan safer. This guide explains what each medication does, what it does not do, and the specific questions worth asking a detox team before the first dose.

Lofexidine and Clonidine in Opioid Detox: The Short Version

Lofexidine (brand name Lucemyra) and clonidine are both alpha-2 adrenergic agonists, a class of non-opioid medications that calm the nervous-system surge behind many opioid withdrawal symptoms. Lofexidine was approved by the U.S. Food and Drug Administration in 2018 as the first non-opioid medication for opioid withdrawal symptoms in adults, and its label covers treatment for up to 14 days. Clonidine is a blood pressure medication that has been used off-label for opioid withdrawal for decades. Both can lower blood pressure and slow the heart rate, so each dose in a supervised detox is usually tied to a vital-sign check. Neither medication treats opioid cravings or the underlying opioid use disorder; that is the job of medications such as buprenorphine, methadone or naltrexone, which should be planned before the alpha-2 medication is stopped.

Why Opioid Withdrawal Feels the Way It Does

Opioid withdrawal is rarely life-threatening on its own in otherwise healthy adults, but it is miserable, and the misery is a leading reason people leave detox early. Several mechanisms are at work at once:

• Noradrenaline rebound: with opioids suddenly gone, a brainstem region called the locus coeruleus fires excessively, producing sweating, chills, goosebumps, a racing heart, restlessness and anxiety.
• Loss of opioid effect in the gut: opioids slow the bowel, so stopping them brings cramping, nausea, vomiting and diarrhea, which in turn raise the risk of dehydration.
• Disrupted sleep: insomnia commonly runs through the acute phase and can linger after other symptoms fade.
• Cravings: the drive to use is driven by changes in the brain’s reward and stress systems, which alpha-2 medications barely touch.

Alpha-2 medications mainly target the first item on that list. That is why a detox plan typically pairs them with other symptom medications for nausea, diarrhea, muscle aches and sleep, and why they cannot carry recovery by themselves. The National Institute on Drug Abuse describes medications for opioid use disorder as the evidence-based core of treatment, with withdrawal management as a first step rather than the whole of care.

How Lofexidine and Clonidine Differ in Practice

The two drugs work in a similar way, so the practical differences are about labeling, side effects and access rather than effect.

• Labeling: lofexidine is FDA-approved specifically for opioid withdrawal symptoms; clonidine is approved for high blood pressure and used off-label in detox.
• Blood pressure: clinicians generally regard lofexidine as somewhat less likely to drop blood pressure than clonidine, though both can, and low blood pressure, dizziness and fainting remain the main safety concerns for both.
• Heart rhythm: lofexidine’s label carries a warning about QT prolongation, a change in heart rhythm, which matters for people taking methadone, some antidepressants or other QT-affecting medications.
• Cost and coverage: clonidine is an inexpensive generic; lofexidine is a brand-name product and may require prior authorization depending on the insurer, which can delay a planned start.
• Stopping: both should be reduced gradually rather than stopped abruptly, because a sudden stop can cause rebound high blood pressure. Lofexidine’s label describes tapering over 2 to 4 days.

Neither choice is automatically better. The prescriber weighs heart history, current blood pressure, other medications and coverage.

The Operational Detail That Matters Most: Hold Parameters

In a supervised detox, every dose of lofexidine or clonidine is usually given only after a blood pressure and pulse check. The prescriber writes “hold parameters” into the order: specific readings below which the dose is skipped and the clinician is notified. In a small residence such as Annandale’s six-bed home in the Los Angeles and Pasadena area, that check happens at the bedside before each scheduled dose, which is one reason these medications are much easier to use safely under supervision than at home, where nobody is measuring before the next tablet.

Two practical points come up repeatedly at intake. First, many people already take a medication from the same class without realizing it: clonidine or guanfacine is sometimes prescribed for blood pressure, sleep, or ADHD. Doubling up on alpha-2 medications can push blood pressure too low, so those prescriptions need to be on the intake list. Second, dehydration from vomiting and diarrhea makes low blood pressure more likely, which is why fluids and anti-nausea care are part of the same plan rather than an afterthought.

What to Ask Before Admission

You can do this today. Before a detox admission, write down every current prescription (including any blood pressure, sleep or ADHD medication), your usual resting blood pressure if you know it, and the date and amount of your last opioid use, including whether it was fentanyl. Then ask the admissions team these four questions on your next call:

1. Which withdrawal medication do you plan to use, lofexidine, clonidine or something else, and why for me?
2. What are the written hold parameters for blood pressure and pulse, and who checks them overnight?
3. What is the plan for starting buprenorphine, methadone or naltrexone, and on what day?
4. If I am also using alcohol or benzodiazepines, how will that withdrawal be monitored?

Our admissions team can walk through these questions with you at (855) 778-8668. You can also read more about our medical detox program in Los Angeles.

Plan the Next Medication Before the Last Alpha-2 Dose

Because lofexidine is labeled for up to 14 days and both medications are tapered, the detox plan should name the next step well before the taper ends. For many people, that next step is buprenorphine, which can be started once withdrawal is sufficiently established; SAMHSA describes buprenorphine as a medication that reduces cravings and withdrawal as part of a broader treatment plan. Others choose extended-release naltrexone, which requires a period without opioids first. Our Suboxone treatment page explains how buprenorphine fits into residential care.

This planning matters for safety. After detox, tolerance falls quickly, and a return to a previous dose, especially of fentanyl, carries a high overdose risk. The CDC’s overdose prevention resources encourage keeping naloxone on hand, and leaving detox with naloxone and a scheduled follow-up is a reasonable expectation to set at admission.

Mixed Use: When Alcohol or Benzodiazepines Are Involved

Many people entering opioid detox are also drinking or taking benzodiazepines. That changes the risk profile considerably. Unlike opioid withdrawal, withdrawal from alcohol and benzodiazepines can cause seizures and, in the case of alcohol, delirium tremens, so it requires medical supervision and should never be attempted alone. Alpha-2 medications can also add to the sedation caused by alcohol, benzodiazepines and other sedatives, which is another reason the full substance history needs to be shared honestly at intake. The American Society of Addiction Medicine’s clinical guidelines address withdrawal management for each substance separately because the risks differ.

When Opioid Use Comes With Depression, Anxiety or Trauma

Restlessness, anxiety and poor sleep during withdrawal can look like a worsening mental health condition, and sometimes they unmask one. For people being treated for opioid use disorder alongside co-occurring depression, anxiety, PTSD or ADHD, a dual diagnosis approach means psychiatric symptoms are assessed after the acute withdrawal settles, rather than diagnosed in the middle of it, and existing psychiatric medications are reviewed for interactions with the detox plan. Learn more on our dual diagnosis treatment page.

Key Takeaways

• Lofexidine and clonidine ease withdrawal symptoms; they do not treat opioid use disorder.
• Both can lower blood pressure and heart rate, so supervised dosing with written hold parameters is standard.
• List any blood pressure, sleep or ADHD medications at intake, especially clonidine or guanfacine.
• Agree on the next medication, such as buprenorphine or naltrexone, before the alpha-2 taper ends.
• Alcohol or benzodiazepine use alongside opioids requires medical supervision because of seizure risk.

If you are ready to talk through a detox plan, call (855) 778-8668 to speak with our admissions team.

This article is for educational purposes only and is not medical advice. Do not start, stop or change any medication without guidance from a qualified clinician. If you or someone else is experiencing a medical emergency or possible overdose, call 911. If you are in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline. For free, confidential treatment referrals, contact the SAMHSA National Helpline at 1-800-662-4357.